$29.24
1.746.35%
al cierre: -
$29.24
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Assembly Biosciences Actividad de operaciones con información privilegiada
ASMBNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Assembly Biosciences. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Assembly Biosciences.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Assembly Biosciences Inc los iniciados?
En Assembly Biosciences Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders no han reportado ventas en los últimos 30 días, mientras tanto, los insiders han informado haber comprado un total de 2.30M acciones por un valor total de -.
Compras y ventas recientes notables de información privilegiada
- El octubre 3, 2025, GILEAD SCIENCES INC, la empresa 10% OWNER purchased 2.3M acciones por - cada una.
Estadísticas de propiedad de Assembly Biosciences Inc
Acciones en circulación
7.672M
Acciones en manos de personas con información privilegiada
2.438M
Porcentaje de acciones en manos de personas con información privilegiada
15.7%
Acciones en manos de instituciones
1.001M
Porcentaje de acciones en manos de instituciones
6.43%
Oct 03, 2025 | 10% OWNER | 2.30M | $0.00 | $0.00 | BUY | 103.91% | 4.51M | Aug 08 | ||
Apr 15, 2025 | — | -757.00 | $9.85 | -$7.46K | SELL | -3.96% | 18.35K | Mar 31 | ||
Apr 01, 2025 | PRINCIPAL ACCOUNTING OFFICER | 1.48K | $9.85 | -$1.77K | GRANT | 46.94% | 4.62K | Mar 29 - Mar 31 | ||
Apr 01, 2025 | CEO AND PRESIDENT | -355.00 | $9.85 | -$3.50K | SELL | -2.35% | 14.76K | Mar 31 | ||
Apr 01, 2025 | CHIEF MANUFACTURING OFFICER | -197.00 | $9.85 | -$1.94K | SELL | -1.66% | 11.67K | Mar 31 | ||
Dec 31, 2024 | — | 3.20K | $15.61 | $50.00K | BUY | ∞ | 3.20K | Dec 30 | ||
Dec 23, 2024 | 10% OWNER | 940.50K | $21.37 | $20.10M | BUY | 74.12% | 2.21M | Dec 19 | ||
Nov 26, 2024 | 10% OWNER | 25.00K | $14.88 | $371.99K | BUY | 3.56% | 728.11K | Nov 22 - Nov 25 | ||
Nov 19, 2024 | CHIEF MANUFACTURING OFFICER | -40.00 | $16.29 | -$651.60 | SELL | -0.34% | 11.87K | Nov 18 | ||
Oct 09, 2024 | 10% OWNER | 10.00K | $14.58 | $145.80K | BUY | 1.44% | 703.11K | Oct 08 | ||
Oct 04, 2024 | CHIEF MANUFACTURING OFFICER | -157.00 | $14.81 | -$2.33K | SELL | -1.30% | 11.91K | Oct 03 | ||
Oct 04, 2024 | CEO AND PRESIDENT | -197.00 | $14.81 | -$2.92K | SELL | -1.30% | 14.90K | Oct 03 | ||
Aug 05, 2024 | CHIEF MANUFACTURING OFFICER | -785.00 | $14.23 | -$11.17K | SELL | -6.11% | 12.07K | Aug 02 | ||
Aug 05, 2024 | CEO AND PRESIDENT | -981.00 | $14.23 | -$13.96K | SELL | -6.10% | 15.10K | Aug 02 | ||
Jul 08, 2024 | 10% OWNER | 9.00K | $12.40 | $111.63K | BUY | 1.32% | 693.11K | Jul 03 - Jul 05 | ||
Jun 20, 2024 | 10% OWNER | 179.50K | $0.00 | $0.00 | BUY | 16.48% | 1.27M | Jun 17 | ||
May 24, 2024 | PRINCIPAL ACCOUNTING OFFICER | -24.00 | $14.93 | -$358.41 | SELL | -0.76% | 3.14K | May 23 | ||
May 24, 2024 | — | -2.12K | $14.93 | -$31.61K | SELL | -9.98% | 19.10K | May 23 | ||
May 24, 2024 | CHIEF MANUFACTURING OFFICER | -172.00 | $14.93 | -$2.57K | SELL | -1.32% | 12.85K | May 23 | ||
May 24, 2024 | CEO AND PRESIDENT | -549.00 | $14.93 | -$8.20K | SELL | -3.30% | 16.08K | May 23 | ||
May 01, 2024 | CHIEF MANUFACTURING OFFICER | 2.08K | $12.71 | -$15.95K | GRANT | 18.98% | 13.03K | Apr 29 - Apr 30 | ||
May 01, 2024 | CEO AND PRESIDENT | 2.60K | $12.71 | -$19.94K | GRANT | 18.78% | 16.42K | Apr 29 - Apr 30 | ||
Apr 02, 2024 | — | -1.21K | $13.07 | -$15.76K | SELL | -5.38% | 21.22K | Apr 01 | ||
Apr 02, 2024 | PRINCIPAL ACCOUNTING OFFICER | 736.00 | $13.07 | -$1.49K | GRANT | 30.29% | 3.17K | Mar 29 - Apr 01 | ||
Apr 02, 2024 | CHIEF MANUFACTURING OFFICER | -197.00 | $13.07 | -$2.58K | SELL | -1.77% | 10.95K | Apr 01 | ||
Apr 02, 2024 | CEO AND PRESIDENT | -354.00 | $13.07 | -$4.63K | SELL | -2.50% | 13.83K | Apr 01 | ||
Mar 29, 2024 | CEO AND PRESIDENT | -392.00 | $12.87 | -$5.05K | SELL | -2.69% | 14.18K | Mar 27 | ||
Jan 19, 2024 | 10% OWNER | 645.08K | $0.79 | $511.26K | BUY | 8.53% | 8.21M | Jan 17 - Jan 18 | ||
Nov 22, 2023 | 10% OWNER | 400.00K | $0.71 | $282.10K | BUY | 5.58% | 7.56M | Nov 20 - Nov 21 | ||
Nov 21, 2023 | CHIEF MANUFACTURING OFFICER | -477.00 | $0.69 | -$328.65 | SELL | -0.51% | 93.77K | Nov 17 | ||
Oct 04, 2023 | CHIEF MANUFACTURING OFFICER | 8.11K | $0.80 | -$1.50K | GRANT | 9.41% | 94.25K | Oct 02 - Oct 03 | ||
Oct 04, 2023 | CHIEF SCIENTIFIC OFFICER | 8.11K | $0.80 | -$1.50K | GRANT | 5.68% | 150.85K | Oct 02 - Oct 03 | ||
Oct 04, 2023 | CEO AND PRESIDENT | 10.14K | $0.80 | -$1.88K | GRANT | 6.15% | 174.92K | Oct 02 - Oct 03 | ||
Aug 03, 2023 | CHIEF SCIENTIFIC OFFICER | -9.46K | $1.09 | -$10.29K | SELL | -6.22% | 142.74K | Aug 02 | ||
Aug 03, 2023 | CEO AND PRESIDENT | -11.83K | $1.09 | -$12.87K | SELL | -6.70% | 164.79K | Aug 02 | ||
Jul 25, 2023 | PRINCIPAL ACCOUNTING OFFICER | -844.00 | $1.07 | -$900.38 | SELL | -3.07% | 26.69K | Jul 24 | ||
May 31, 2023 | CHIEF SCIENTIFIC OFFICER | -4.23K | $0.96 | -$4.05K | SELL | -3.63% | 112.20K | May 30 | ||
May 24, 2023 | DIRECTOR | 91.53K | $1.04 | -$27.02K | GRANT | 117.90% | 169.16K | May 22 - May 23 | ||
May 24, 2023 | PRINCIPAL ACCOUNTING OFFICER | 1.23K | $1.04 | -$285.04 | GRANT | 4.66% | 27.53K | May 22 - May 23 | ||
May 24, 2023 | CHIEF SCIENTIFIC OFFICER | 28.44K | $1.04 | -$6.83K | GRANT | 32.32% | 116.44K | May 22 - May 23 | ||
May 24, 2023 | CEO AND PRESIDENT | 28.44K | $1.04 | -$6.83K | GRANT | 28.97% | 126.61K | May 22 - May 23 | ||
Mar 31, 2023 | DIRECTOR | -14.88K | $0.82 | -$12.25K | SELL | -7.73% | 177.63K | Mar 30 | ||
Mar 31, 2023 | PRINCIPAL ACCOUNTING OFFICER | 5.48K | $0.82 | -$637.16 | GRANT | 29.87% | 23.81K | Mar 29 - Mar 30 | ||
Mar 31, 2023 | CHIEF SCIENTIFIC OFFICER | -3.42K | $0.82 | -$2.82K | SELL | -3.85% | 85.50K | Mar 30 | ||
Mar 31, 2023 | CEO AND PRESIDENT | -4.25K | $0.82 | -$3.50K | SELL | -4.15% | 98.17K | Mar 30 | ||
Mar 28, 2023 | CEO AND PRESIDENT | -4.69K | $1.02 | -$4.78K | SELL | -4.38% | 102.42K | Mar 27 | ||
Aug 10, 2022 | CHIEF EXECUTIVE OFFICER | -12.31K | $2.13 | -$26.20K | SELL | -6.01% | 192.51K | Aug 08 | ||
Jul 26, 2022 | CHIEF FINANCIAL OFFICER | -2.02K | $2.22 | -$4.48K | SELL | -2.55% | 77.23K | Jul 25 | ||
Jun 02, 2022 | CHIEF SCIENTIFIC OFFICER | -4.16K | $1.92 | -$8.00K | SELL | -5.17% | 76.42K | May 31 | ||
Mar 31, 2022 | CHIEF FINANCIAL OFFICER | 23.96K | $2.17 | -$4.95K | GRANT | 45.40% | 76.75K | Mar 29 - Mar 30 | ||
Mar 31, 2022 | CHIEF MEDICAL OFFICER | 21.46K | $2.17 | -$2.25K | GRANT | 113.84% | 40.31K | Mar 29 - Mar 30 | ||
Mar 31, 2022 | CHIEF SCIENTIFIC OFFICER | 23.96K | $2.17 | -$2.25K | GRANT | 44.27% | 78.08K | Mar 29 - Mar 30 | ||
Mar 31, 2022 | CHIEF OPERATING OFFICER | 29.98K | $2.17 | -$2.75K | GRANT | 46.39% | 94.61K | Mar 29 - Mar 30 | ||
Mar 31, 2022 | CEO AND PRESIDENT | 79.14K | $2.17 | -$10.00K | GRANT | 62.96% | 204.83K | Mar 29 - Mar 30 | ||
Mar 29, 2022 | CHIEF OPERATING OFFICER | -4.62K | $2.24 | -$10.36K | SELL | -6.67% | 64.63K | Mar 28 | ||
Aug 10, 2021 | CEO AND PRESIDENT | -12.16K | $3.60 | -$43.78K | SELL | -8.82% | 125.69K | Aug 09 | ||
Jun 01, 2021 | CHIEF SCIENTIFIC OFFICER | -4.13K | $4.03 | -$16.64K | SELL | -7.21% | 53.12K | May 27 | ||
Dec 15, 2020 | — | -1.30K | $6.15 | -$7.98K | SELL | -3.35% | 37.36K | Dec 14 | ||
Nov 10, 2020 | — | -4.40K | $5.10 | -$22.40K | SELL | -36.64% | 7.60K | Nov 09 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.